267 related articles for article (PubMed ID: 33466775)
1. Biologically Active Tissue Factor-Bearing Larger Ectosome-Like Extracellular Vesicles in Malignant Effusions from Ovarian Cancer Patients: Correlation with Incidence of Thrombosis.
Steidel C; Ender F; Rody A; von Bubnoff N; Gieseler F
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466775
[TBL] [Abstract][Full Text] [Related]
2. High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors.
Koizume S; Ito S; Yoshioka Y; Kanayama T; Nakamura Y; Yoshihara M; Yamada R; Ochiya T; Ruf W; Miyagi E; Hirahara F; Miyagi Y
Thromb Haemost; 2016 Jan; 115(2):299-310. PubMed ID: 26446354
[TBL] [Abstract][Full Text] [Related]
3. Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers.
Yamamoto CM; Oakes ML; Murakami T; Muto MG; Berkowitz RS; Ng SW
J Ovarian Res; 2018 Mar; 11(1):20. PubMed ID: 29499737
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells.
Mitra A; Yoshida-Court K; Solley TN; Mikkelson M; Yeung CLA; Nick A; Lu K; Klopp AH
Sci Rep; 2021 Apr; 11(1):9149. PubMed ID: 33911091
[TBL] [Abstract][Full Text] [Related]
5. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.
Gomes FG; Sandim V; Almeida VH; Rondon AMR; Succar BB; Hottz ED; Leal AC; Verçoza BRF; Rodrigues JCF; Bozza PT; Zingali RB; Monteiro RQ
Thromb Res; 2017 Nov; 159():24-32. PubMed ID: 28950217
[TBL] [Abstract][Full Text] [Related]
6. Small extracellular vesicles from malignant ascites of patients with advanced ovarian cancer provide insights into the dynamics of the extracellular matrix.
Bortot B; Apollonio M; Rampazzo E; Valle F; Brucale M; Ridolfi A; Ura B; Addobbati R; Di Lorenzo G; Romano F; Buonomo F; Ripepi C; Ricci G; Biffi S
Mol Oncol; 2021 Dec; 15(12):3596-3614. PubMed ID: 34614287
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles from malignant effusions induce tumor cell migration: inhibitory effect of LMWH tinzaparin.
Gamperl H; Plattfaut C; Freund A; Quecke T; Theophil F; Gieseler F
Cell Biol Int; 2016 Oct; 40(10):1050-61. PubMed ID: 27435911
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer.
Vyhlídalová Kotrbová A; Gömöryová K; Mikulová A; Plešingerová H; Sladeček S; Kravec M; Hrachovinová Š; Potěšil D; Dunsmore G; Blériot C; Bied M; Kotouček J; Bednaříková M; Hausnerová J; Minář L; Crha I; Felsinger M; Zdráhal Z; Ginhoux F; Weinberger V; Bryja V; Pospíchalová V
J Extracell Vesicles; 2024 Mar; 13(3):e12420. PubMed ID: 38490958
[TBL] [Abstract][Full Text] [Related]
9. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.
Yokoi A; Yoshioka Y; Yamamoto Y; Ishikawa M; Ikeda SI; Kato T; Kiyono T; Takeshita F; Kajiyama H; Kikkawa F; Ochiya T
Nat Commun; 2017 Mar; 8():14470. PubMed ID: 28262727
[TBL] [Abstract][Full Text] [Related]
10. Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis.
Almeida VH; Rondon AMR; Gomes T; Monteiro RQ
Cells; 2019 Jul; 8(7):. PubMed ID: 31337034
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor activity on microvesicles from cancer patients.
Ender F; Freund A; Quecke T; Steidel C; Zamzow P; von Bubnoff N; Gieseler F
J Cancer Res Clin Oncol; 2020 Feb; 146(2):467-475. PubMed ID: 31734835
[TBL] [Abstract][Full Text] [Related]
12. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Yokota N; Koizume S; Miyagi E; Hirahara F; Nakamura Y; Kikuchi K; Ruf W; Sakuma Y; Tsuchiya E; Miyagi Y
Br J Cancer; 2009 Dec; 101(12):2023-9. PubMed ID: 19904262
[TBL] [Abstract][Full Text] [Related]
13. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
[TBL] [Abstract][Full Text] [Related]
14. Differential biomarker profiles between unprovoked venous thromboembolism and cancer.
Sánchez-López V; Gao L; Ferrer-Galván M; Arellano-Orden E; Elías-Hernández T; Jara-Palomares L; Asensio-Cruz MI; Castro-Pérez MJ; Rodríguez-Martorell FJ; Lobo-Beristain JL; Ballaz-Quincoces A; López-Campos JL; Vila-Liante V; Otero-Candelera R
Ann Med; 2020 Sep; 52(6):310-320. PubMed ID: 32634035
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.
Zwicker JI; Liebman HA; Neuberg D; Lacroix R; Bauer KA; Furie BC; Furie B
Clin Cancer Res; 2009 Nov; 15(22):6830-40. PubMed ID: 19861441
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.
van Es N; Hisada Y; Di Nisio M; Cesarman G; Kleinjan A; Mahé I; Otten HM; Kamphuisen PW; Berckmans RJ; Büller HR; Mackman N; Nieuwland R
Thromb Res; 2018 Jun; 166():54-59. PubMed ID: 29656167
[TBL] [Abstract][Full Text] [Related]
17. Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
Boddu VK; Zamzow P; Kramer MW; Merseburger AS; Gorantla SP; Klinger M; Cramer L; Sauer T; Gemoll T; von Bubnoff N; Gieseler F; Darabi M
Cell Commun Signal; 2024 Feb; 22(1):129. PubMed ID: 38360687
[TBL] [Abstract][Full Text] [Related]
18. EV-Associated MMP9 in High-Grade Serous Ovarian Cancer Is Preferentially Localized to Annexin V-Binding EVs.
Reiner AT; Tan S; Agreiter C; Auer K; Bachmayr-Heyda A; Aust S; Pecha N; Mandorfer M; Pils D; Brisson AR; Zeillinger R; Lim SK
Dis Markers; 2017; 2017():9653194. PubMed ID: 28607529
[TBL] [Abstract][Full Text] [Related]
19. Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells.
Lane D; Robert V; Grondin R; Rancourt C; Piché A
Int J Cancer; 2007 Sep; 121(6):1227-37. PubMed ID: 17534891
[TBL] [Abstract][Full Text] [Related]
20. Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.
Hisada Y; Mackman N
Curr Opin Hematol; 2019 Sep; 26(5):349-356. PubMed ID: 31261175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]